Riskpilot← Back to searchSign inGet full accessAMFIBIEN AS
ASActiveOrg 989190148Dyre Halses Gate 18, 7042 TrondheimRental and operating of own or leased real estate · NACE 6820Est. 20060 employees
Revenue 2024
NOK 0
EBITDA margin
—
-177% vs 2023
Equity ratio
86.2%
Financial strength
Net profit 2024
NOK -19M
-261% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -462K | -177% |
| Net profit | NOK -19M | -261% |
| Total assets | NOK 142,3M | -17% |
| Equity | NOK 122,6M | -18% |
| Employees | 0 | — |
Legal name
AMFIBIEN AS
Org number
989190148
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
10. januar 2006
Share capital
NOK 33 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Investere i verdipapirer / eiendom og / eller andre investeringsalternativer som måtte avdekkes , med det formål å maksimere avkastning for eierne.
Address
Dyre Halses Gate 18, 7042 Trondheim
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 101 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −67 |
| EBITDA | −96 | −75 | −13 | −166 | −462 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −96 | −75 | −13 | −166 | −462 |
| Net financials | −4 659 | 127 414 | 10 966 | 11 933 | −18 496 |
| Profit before tax | −4 755 | 127 339 | 10 953 | 11 767 | −18 957 |
| Tax | −326 | −0 | 1 073 | −0 | −0 |
| Net profit | −4 430 | 127 339 | 9 879 | 11 767 | −18 957 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 39 061 | 128 844 | 140 800 | 171 470 | 142 318 |
| Equity | 37 608 | 127 646 | 137 526 | 149 293 | 122 635 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 453 | 1 198 | 3 275 | 22 177 | 19 683 |
| Total debt | 1 453 | 1 198 | 3 275 | 22 177 | 19 683 |
EBITDA margin
-46189800.0%
This company
15.8%
Market median
-292340606% vs market
20202024
Equity ratio
86.2%
This company
38.2%
Market median
+126% vs market
20202024
Return on equity
-15.5%
This company
18.4%
Market median
-184% vs market
20202024
Net profit margin
-1895749700.0%
This company
8.1%
Market median
-23404317384% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EA Deputy Member | Deputy Member | 2006 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2006 | |
| Board of Directors | 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AMFIBIEN AS 
LOZ ASBoard members of AMFIBIEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Egil Arnt Hestad | Deputy Member | 0 companies |
| John Hestad | Chairman | 0 companies |
| Gaute Angen Hestad | Board of Directors | 0 companies |